THOC1 complexes with SIN3A to regulate R-loops and promote glioblastoma progression
Abstract
Glioblastoma (GBM), the most common and aggressive primary malignant brain tumor in adults, has a median survival of 14.6 months. To identify drivers of GBM pathogenesis, we conducted a CRISPR-knockout screen, which revealed THO Complex 1 (THOC1) as a key driver. Knocking down THOC1 significantly reduced GBM cell viability across patient-derived xenograft (PDX) lines, enhancing survival (p
Fields of Study & Subjects
DNA Repair Mechanisms
Glioma Diagnosis and Treatment
Epigenetics and DNA Methylation
Publication details
- Journal / source
- Neoplasia
- Volume
- 72
- Pages
- 101271–101271
- Publication date
- 6 January 2026
- Language
- EN